3Internet News Record
Missiles before talks — what’s themessage from Iran?
By Tabassum Zakaria (Front Row Washington)
Submitted at 9/28/2009 9:28:38 AM
Everyone has their own way of broaching subjects they don’t like.Iran has decided the bestprelude to upcoming talks withWestern powers that areinevitably going to end up in afinger-pointing session overTehran’s nuclear program, is totest fire a bunch of missiles.The United States has madeclear it will focus on Iran’snuclear program at the meetingThursday in Geneva. Let’s see if the traditional neutrality of theSwiss venue makes a difference inkeeping tempers in check (chocolates anyone?).So what’s Iran trying to saywith the missile launches whichcome inbetween last week’sdisclosure that Tehran is buildinga second uranium enrichmentplant and this week’s rare meetingbetween Iran and six majorpowers including the UnitedStates, China and Russia.“It’s entirely unsurprising thatthe Iranians would pop off someshort- and medium-range missilesin the run-up to talks,” a U.S.counterproliferation official tellsReuters.“They could be doing this fordomestic reasons as a show of strength to their own peoplebefore sitting down with themajor powers,” the official says.“Of course, it’s also possible thatthey conducted these tests todeflect attention away fromgetting caught with their hands inthe nuclear cookie jar,” the officalsays.What do you think the missiletest message is all about? How doyou think these talks will go? Willthe threat of more sanctions onTehran have any impact?Photo Credit: Reuters/ArndWiegmann (swiss chocolates),Reuters/stringer (Iranian longrange missile test-fired)
UK teenager "unlikely"to have died fromvaccine - Reuters
(Most Popular - Google News)
Submitted at 9/29/2009 6:23:08 AM
* Post-mortem under way todetermine cause of death* Batch of vaccine involvedquarantinedBy Matthew JonesLONDON, Sept 29 (Reuters) -GlaxoSmithKline's ( GSK.L)cervical cancer vaccine Cervarixprobably did not cause the deathof a British teenager shortly aftershe was given the drug, a healthofficial said on Tuesday."I think it is unlikely that will bethe case," said Dr Caron Grainger, joint director of public health inthe area where the 14-year-oldgirl died, when asked about thepossibility of any connectionbetween the death and Cervarix.News of the death came shortlybefore a possible decision by U.S.health regulators on whether toapprove Cervarix for sale in theUnited States."I think once we get into theinvestigation ... we may discoverthere is another cause of herdeath," Grainger told the BBC."The message for parents at thismoment in time and for younggirls receiving this vaccine is thatyou should go ahead with thevaccination," said Grainger, whoworks for the National HealthService in the central English cityof Coventry.Police are treating the girl'sdeath as "unexplained" and said apost-mortem was taking place onTuesday.The teenager, named by a policesource as Natalie Morton, fell illon Monday after being vaccinatedat her school under a nationalimmunisation programme againstthe sexually-transmitted humanpapilloma virus (HPV).NO PLANS TO HALTPROGRAMBritain's Department of Healthsaid there were no plans to haltthe programme under which morethan 1.4 million doses of Cervarixhave been administered. "Thevaccine has a strong safety recordso precautionary measures arefocused on the batch," it said in astatement.Grainger said only about 2,000people had suffered any adversereactions to the immunisationprogramme and that these weremostly minor. GlaxoSmithKlinesaid on Monday it was workingwith regulators to understand thecase better.Sudden teenage deaths, ingeneral, are not unknown."Unfortunately, some youngpeople do die suddenly for avariety of reasons, includingcardiac causes. Sometimes theyhave been entirely well beforetheir death," said Dr DavidElliman of London's GreatOrmond Street Hospital forChildren. Continued...
Newmont is still mining the right commodities
By Joseph Lazzaro (BloggingStocks)
Submitted at 9/29/2009 9:00:00 AM
Filed under: Newmont Mining(NEM), Stocks to Buy NewmontMining's(NYSE: NEM) stock continues to meander, despite anaverage, higher price for gold sofar in 2009. The primary culprit?An average, lower price forcopper.Still, with a likely FY2009revenue gain of 6-7%, I'mReiterating my Buy rating for thecompany, first recommended onJune 3, 2009 at a price of $46.42.Continue reading Newmont isstill mining the right commoditiesNewmont is still mining theright commodities originallyappeared on BloggingStocks onTue, 29 Sep 2009 09:00:00 EST.Please see our terms for use of feeds. Permalink| Email this|Comments
Politics/ Top News/ Finance/